Pay in 4 interest-free payments of $30.25 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
Studies indicate that the P2X3 receptor is implicated in both neuropathic and inflammatory pain
Thalidomide-O-amido-C4-NH2 (Cereblon Ligand-Linker Conjugates 6)
Selective Inhibitor of the Protein Methyltransferase DOT1L for Use in the Treatment of MLL-Rearranged Leukemia
Formula: C37H45N3O14
Miglustat is used to treat adults with mild-to-moderate Type I Gaucher disease and it is the first treatment to be approved for patients with Niemann–Pick type C disease
Brexpiprazole S-oxide D8 Size:Contact [email protected] for quotation Studies indicate that the P2X3Brexpiprazole S oxide D8 (DM 3411 D8) is a deuterium labeled Brexpiprazole S oxide. Brexpiprazole S oxide is a main metabolite of Brexpiprazole and is metabolized by cytochrome P450 3A4 (CYP3A4). Brexpiprazole is an atypical antipsychotic agent and a partial agonist of human 5 HT1A and dopamine receptor with Kis of 0. 12 nM and 0. 3 nM, respectively. Brexpiprazole is also a 5 HT2A receptor antagonist with a Ki of 0. 47 nM. Product information
US$ 290.50
US$ 187.00
US$ 231.50
US$ 263.00